Why is Anuh Pharma falling/rising?

As of 18-Aug, Anuh Pharma Ltd is experiencing a decline in its stock price, currently at Rs 87.30, reflecting a decrease of Rs 1.25 or 1.41%. The stock has been underperforming, having fallen for three consecutive days, with a total return of -1.66% during this period. It has also underperformed its sector by 1.64% today. Additionally, the stock is trading below all its moving averages, indicating a bearish trend. Over the past year, Anuh Pharma has generated a return of -12.20%, significantly worse than the broader market, which has seen a decline of only -1.14%. The company's profits have also decreased by 20.2%, contributing to negative sentiment among investors.
In the broader market context, Anuh Pharma's recent performance contrasts sharply with the Sensex, which has gained 0.83% over the past week. This underperformance is indicative of a lack of investor confidence, further exacerbated by a significant drop in delivery volume, which has fallen by 45.97% compared to the five-day average. While the company maintains a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2.7, the negative results reported in June, including a 29.9% drop in profit after tax, have overshadowed these positives. Overall, the combination of poor long-term growth prospects and recent negative financial results has led to a decline in investor interest, contributing to the stock's downward trajectory.